Tychan Pte Ltd.

ACTIVE

Singaporewww.tychan.comPrivate11–50 employeesEstablished: 2015-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

75.0%

Phase 3

25.0%

Trial Status Distribution

Completed

50.0%

Terminated

25.0%

Withdrawn

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Phase 3

Terminated

interventional

Dec 202017 participants

Safety of TY027, a Treatment for COVID-19, in Humans

Phase 1

Completed

interventional

Jun 202032 participants

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients

Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Phase 1

Completed

interventional

Feb 201824 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations